Harmony Biosciences Says New Data Supports Neurology Pipeline - Harmony Biosciences Hldgs (NASDAQ:HRMY)

Harmony Biosciences stock jumped after record Q2 revenue, an earnings beat, strong WAKIX sales and updated analyst price targets.

Raccontata dabenzinga.com